Immunotherapy in the Initial Treatment of Newly Diagnosed Cancer Patients: Utilization Trend and Cost Projections for Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, and Metastatic Colorectal Cancer

Author： Shih Ya-Chen Tina   Elting Linda S.   Pavluck Alexandre L.   Stewart Andrew   Halpern Michael T.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.28, Iss.1, 2010-01, pp. : 46-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal Doxorubicin: A Review of its Use in Metastatic Breast Cancer and Potential in Non-Hodgkin Lymphoma

By Dando Toni M.   Keating Gillian M.  

American Journal of Cancer, Vol. 4, Iss. 3, 2005-01 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite

Bevacizumab in the treatment of metastatic colorectal cancer

By Caprioni Francesco   Fornarini Giuseppe  

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 141-148

Future Medicine

Access to resources Recommend Favorite

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer

By                

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 2057-2063

Spandidos Publications

Access to resources Recommend Favorite

XELIRI compared with FOLFIRI as a secondline treatment in patients with metastatic colorectal cancer

By                  

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1864-1872

Spandidos Publications

Access to resources Recommend Favorite